2012		2013		2014		Rate (Cases per 100,000 per month)		Monthly Rate Comparison
Disease	Feb No.	YTD No.	Feb No.	YTD No.	Feb No.	YTD No.	Feb (2009-2013 aggregated)	Feb (2014)	Significant change bet. current & past 5-year?~~
Vaccine Preventable
Diphtheria	0	0	0	0	0	0	0.00	0.00
Haemophilus Influenza (Invasive)	.	.	.	.	.	.	0.07	0.05
Hepatitis A	.	.	.	.	0	.	0.04	0.00
Hepatitis B (Acute)	.	10	.	.	.	.	0.13	0.05
Influenza**	43	59	110	381	84	339	4.44	4.16
Measles	0	0	0	0	0	0	0.00	0.00
Mumps	0	0	0	0	0	0	0.00	0.00
Pertussis	0	.	7	22	.	7	0.07	0.05
Poliomyelitis	0	0	0	0	0	0	0.00	0.00
Rubella	0	0	0	0	0	0	0.00	0.00
Tetanus	0	0	0	0	0	0	0.00	0.00
Sexually Transmitted
AIDS	17	41	19	35	12	33	0.91	0.59
Chlamydia	752	1427	766	1480	559	1348	37.49	27.66	X
Gonorrhea	133	265	180	367	127	313	8.60	6.28	X
HIV	22	43	14	35	17	42	0.97	0.84
Syphilis (Early Latent)	17	37	20	44	15	35	0.87	0.74
Syphilis (Primary & Secondary)	.	12	11	19	20	42	0.41	0.99	X
Enterics
Amebiasis	0	.	0	.	0	0	0.00	0.00
Botulism-Intestinal (Infant)	0	0	0	0	0	0	0.00	0.00
Campylobacteriosis	6	16	5	10	7	15	0.33	0.35
Cholera	0	0	0	0	0	0	0.00	0.00
Cryptosporidiosis	0	0	0	.	0	0	0.00	0.00
Giardia	5	10	5	8	0	.	0.22	0.00	X
Rotavirus	0	0	14	25	.	.	0.16	0.15
Salmonellosis	6	14	9	18	6	10	0.40	0.30
Shiga-Toxin Producing E.COLI#	6	8	.	.	.	.	0.11	0.10
Shigellosis	0	.	.	7	0	.	0.12	0.00	X
Typhoid Fever	0	0	0	0	0	0	0.00	0.00
Vibrio (Non-Cholera)	0	0	0	0	0	.	0.00	0.00
Yersiniosis	0	0	0	.	0	0	0.01	0.00
Other
Anthrax	0	0	0	0	0	0	0.00	0.00
Botulism Intoxication	0	0	0	0	0	0	0.00	0.00
Brucellosis	0	0	0	0	0	0	0.00	0.00
Coccidioidomycosis	10	23	.	7	6	9	0.29	0.30
Dengue Fever	0	0	0	0	0	0	0.00	0.00
Encephalitis	0	0	0	.	0	0	0.01	0.00
Hantavirus	0	0	0	0	0	0	0.00	0.00
Hemolytic Uremic Syndrome (HUS)	0	0	0	0	0	0	0.00	0.00
Hepatitis C (Acute)	.	.	0	0	0	0	0.03	0.00
Hepatitis D	0	0	0	0	0	0	0.00	0.00
Invasive Group A Strep.##	0	0	0	0	0	0	0.03	0.00
Legionellosis	.	.	.	.	.	.	0.05	0.05
Leprosy (Hansen’s Disease)	0	0	0	0	0	0	0.00	0.00
Leptospirosis	0	0	0	0	0	0	0.00	0.00
Listeriosis	0	.	.	.	0	0	0.02	0.00
Lyme Disease	0	.	0	0	0	0	0.01	0.00
Malaria	0	.	0	.	0	0	0.00	0.00
Meningitis, Aseptic/Viral	.	.	.	.	.	.	0.12	0.20
Meningitis Bacterial	.	.	.	.	.	.	0.02	0.05
Meningococcal Disease	.	.	0	0	.	.	0.01	0.05
Plague	0	0	0	0	0	0	0.00	0.00
Psittacosis	0	0	0	0	0	0	0.00	0.00
Q Fever	0	0	0	0	0	0	0.00	0.00
Rabies (Human)	0	0	0	0	0	0	0.00	0.00
Relapsing Fever	0	0	0	0	0	0	0.00	0.00
Rocky Mountain Spotted Fever	0	0	0	0	0	0	0.00	0.00
RSV (Respiratory Syncytial Virus)	298	512	371	858	174	343	18.88	8.61	X
Streptococcus Pneumoniae IPD###	5	12	7	16	5	17	0.26	0.25
Toxic Shock Syn.	0	0	0	0	0	0	0.00	0.00
Toxic Shock Syn. (Streptococcal)	0	.	0	.	.	.	0.00	0.10
Tuberculosis	8	15	.	9	.	.	0.32	0.05
Tularemia	0	0	0	0	0	0	0.00	0.00
Unusual Illness	0	0	0	0	0	0	0.00	0.00
West Nile Virus (Encephalitis)	0	0	0	0	0	0	0.00	0.00
West Nile Virus (Fever)	0	0	0	0	0	0	0.00	0.00

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Ja including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Data suppression denoted by ‘.’ applies if number of cases <5. Monthly disease total reported by OOE=299(reported total=1050). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported monthly cases [suppression applied] for 2012-2014 were respectively 0,.,0; YTD totals 0,.,0).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the monthly disease incidence rates provided a basis for an informal statistical test to determine if the current monthly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current month of this year or previous 5 years aggregated).